1039948-89-4

Basic information

• Product Name: 4-(2-hydroxyethoxy)-3,5-dimethylbenzaldehyde
• Synonyms: 4-(2-hydroxyethoxy)-3,5-dimethylbenzaldehyde
• CAS NO: 1039948-89-4
• Molecular Formula: C₁₁H₁₄O₃
• Molecular Weight: 194.22706
• Mol File: 1039948-89-4.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 4-(2-hydroxyethoxy)-3,5-dimethylbenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-hydroxyethoxy)-3,5-dimethylbenzaldehyde(1039948-89-4)
• EPA Substance Registry System: 4-(2-hydroxyethoxy)-3,5-dimethylbenzaldehyde(1039948-89-4)

Safety Data

• Hazardous Substances Data: 1039948-89-4(Hazardous Substances Data)

Usage

General Description

4-(2-hydroxyethoxy)-3,5-dimethylbenzaldehyde is a compound with the chemical formula C11H14O3. It is a fragrance ingredient and is often used in the formulation of various personal care and cosmetic products. This chemical is known for its sweet and floral scent, and it is used to add a pleasant odor to perfumes, lotions, and other beauty products. However, it is important to note that this compound should be handled and used with care, as it can cause skin and eye irritation in some individuals. Additionally, it is important to follow guidelines and regulations regarding the use of this chemical to ensure safety and effectiveness in product formulations.

Upstream product

• 2233-18-3 4-hydroxy-3,5-dimethylbenzaldehyde 
• 540-51-2 2-bromoethanol 
• 96-49-1 [1,3]-dioxolan-2-one 
• 107-07-3 2-chloro-ethanol 

Downstream Products

• 1202407-35-9 C₁₂H₁₆O₅S 

Relevant articles and documents

Star/linear polymer topology transformation facilitated by mechanical linking of polymer Chains

Topology transformation of a star polymer to a linear polymer is demonstrated for the first time. A three-armed star polymer possessing a mechanical linking of two polymer chains was synthesized by the living ring-opening polymerization of δ-valerolactone

Design, synthesis and biological evaluation of hypolipidemic compounds based on BRD4 inhibitor RVX-208

Bromodomain-containing protein 4 (BRD4) is a new therapeutic target for the treatment of diseases including cardiovascular diseases, cancer, inflammation and central nervous system (CNS) disorders. In this study, we introduced the pharmacophore of fibrates to a BRD4 inhibitor, RVX-208, to design dual-active hypolipidemic compounds, and found that some of new analogues showed favorable hypolipidemic activities. Synthetic accessibility towards this class of compounds optimized RVX-208 as well as would supply more thoughts on hypolipidemic drugs.

NITRIC OXIDE-RELEASING PRODRUG MOLECULE

Provided are a type of compounds that can be used for treating cardiovascular diseases and compositions containing the compounds. The compounds and the compositions can improve lipid metabolism disorders by increasing high-density lipoprotein cholesterol in blood; in addition, the compounds and the compositions can also release nitric oxide, and reduce the onset risk of cardiovascular diseases by means of relaxing blood vessels, lowering blood pressure, inhibiting platelet adhesion and aggregation and maintaining vascular tension, and thus play an important role in preventing and treating the occurrence and development of cardiovascular diseases.